Thermo Fisher Scientific Q1 Earnings Surpass Estimates, CEO Touts 'Strong Performance' Despite Economic Uncertainty
1. TMO's Q1 2025 EPS of $5.15 beat estimates by $0.05. 2. Quarterly sales reached $10.36 billion, surpassing expectations of $10.23 billion. 3. Adjusted operating margin slightly decreased to 21.9% from 22% year-over-year. 4. TMO announced acquisition of Solventum's filtration business for $4.1 billion. 5. Company stock rose 4.23% following positive earnings report.